CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer
2023 · Molecular Cancer · 47 citations
https://doi.org/10.1186/s12943-023-01716-y
L
Lisha Sun
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
890
Citations
18
h-index
27
i10-index
Lisha Sun is an academic researcher from Nantong University. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Cancer Cells and Metastasis & Peptidase Inhibition and Analysis. The author has an h-index of 18, co-authored 63 publications.
ORCID: 0000-0002-4095-5026Papers by this author
worksEstablishment and Verification of a Bagged-Trees-Based Model for Prediction of Sentinel Lymph Node Metastasis for Early Breast Cancer Patients
2019 · Frontiers in Oncology · 27 citations
https://doi.org/10.3389/fonc.2019.00282
Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study
2022 · Frontiers in Oncology · 20 citations
https://doi.org/10.3389/fonc.2022.977226
Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer
2022 · eLife · 17 citations
https://doi.org/10.7554/elife.85246
CD8+ TILs in necrotic tumors after neoadjuvant immunochemotherapy predict outcomes in non-small-cell lung cancer patients
2025 · Signal Transduction and Targeted Therapy · 3 citations
https://doi.org/10.1038/s41392-025-02435-0
A 6-year retrospective study of olanzapine plasma concentration inpatients with schizophrenia CYP1A2 polymorphisms in real-life settings
2024 · Heliyon · 1 citations
https://doi.org/10.1016/j.heliyon.2024.e39367
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat